Haleon plc (HLNCF)

Market Cap	44.43B +1.4%
Revenue (ttm)	14.85B -1.8%
Net Income	2.24B +15.6%
EPS	0.25 +17.8%
Shares Out	n/a
PE Ratio	19.81
Forward PE	18.25
Dividend	0.10 (1.97%)
Ex-Dividend Date	Apr 9, 2026

Volume	7,719
Open	4.920
Previous Close	4.855
Day's Range	4.890 - 4.980
52-Week Range	4.150 - 5.750
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal dr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1715
• Employees: 24,535
• Stock Exchange: OTCMKTS
• Ticker Symbol: HLNCF

Financial Performance

In 2025, Haleon's revenue was 11.03 billion, a decrease of -1.81% compared to the previous year's 11.23 billion. Earnings were 1.67 billion, an increase of 15.60%.

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jul 29, 2026

Data Sources Report a data error